Meagan Rosenberg MD , Aixa Perez Coulter MS, MPH , Victoria Pepper MD , Gregory Banever MD, FAAP, FACS , David Tashjian MD, FAAP, FACS , Kevin Moriarty MD, FAAP, FACS , Michael V. Tirabassi MD, FAAP, FACS
{"title":"小儿抗反流手术减少减酸药物的远期疗效","authors":"Meagan Rosenberg MD , Aixa Perez Coulter MS, MPH , Victoria Pepper MD , Gregory Banever MD, FAAP, FACS , David Tashjian MD, FAAP, FACS , Kevin Moriarty MD, FAAP, FACS , Michael V. Tirabassi MD, FAAP, FACS","doi":"10.1016/j.jss.2025.04.020","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Revision of anti-reflux procedures (ARPs) has contributed to a shift away from surgical management of pediatric gastroesophageal reflux disease. Long-term proton-pump inhibitor and H2 antagonist use, however, is associated with infection and micronutrient malabsorption. This study investigates long-term ARP efficacy in decreasing acid-reduction medication (ARMs) usage.</div></div><div><h3>Methods</h3><div>A retrospective cohort study of pediatric patients undergoing ARP at a single institution was conducted from January 1, 2000 to December 31, 2017, allowing for at least a 6-y follow-up. Eligibility included patients less than 18 y undergoing index ARP. Age, weight, comorbidities, and ARM use were collected. Operative information included procedure type and hospital course. Postoperative information included complications, reoperation, postoperative symptoms, and postoperative ARMs. <em>t</em>-Tests compared continuous outcomes, while chi-square test compared frequency of categorical outcomes.</div></div><div><h3>Results</h3><div>In total, 305 patients were included with a mean (standard deviation) age of 7.2 (6.5) y. In total, 54.7% of patients were male; 70.7% were White, 23% Hispanic, and 5.7% Black. The procedure was laparoscopic for 99.3% and open for 0.7% (<em>n</em> = 2). The most common preoperative symptoms were regurgitation (53.4%) and retrosternal pain (9.2%). Postoperatively, regurgitation remained the most common at 30.8% (<em>n</em> = 94). The most common comorbidities were neurodevelopmental delay (42%, <em>n</em> = 128) and asthma (35.7%, <em>n</em> = 109). 11.8% (<em>n</em> = 33) underwent reoperation. Subsequently, 2.4% (<em>n</em> = 7) of the patients were within 90 d of operation, most commonly for wrap slippage (<em>n</em> = 11) or hiatal hernia (<em>n</em> = 9). AMRs were discontinued in 39.8% (<em>n</em> = 80) of the patients within 30 d and 57.4% (<em>n</em> = 156) at most recent follow-up. It appeared most efficacious for neurodevelopmental delay patients. The mean follow-up was 10 y.</div></div><div><h3>Conclusions</h3><div>More than half of the patients discontinued ARMs following ARP suggesting that surgery remains beneficial in reducing long-term medication use.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"311 ","pages":"Pages 112-117"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term Efficacy of Pediatric Anti-reflux Surgery in Reduction of Acid-reducing Medication\",\"authors\":\"Meagan Rosenberg MD , Aixa Perez Coulter MS, MPH , Victoria Pepper MD , Gregory Banever MD, FAAP, FACS , David Tashjian MD, FAAP, FACS , Kevin Moriarty MD, FAAP, FACS , Michael V. Tirabassi MD, FAAP, FACS\",\"doi\":\"10.1016/j.jss.2025.04.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Revision of anti-reflux procedures (ARPs) has contributed to a shift away from surgical management of pediatric gastroesophageal reflux disease. Long-term proton-pump inhibitor and H2 antagonist use, however, is associated with infection and micronutrient malabsorption. This study investigates long-term ARP efficacy in decreasing acid-reduction medication (ARMs) usage.</div></div><div><h3>Methods</h3><div>A retrospective cohort study of pediatric patients undergoing ARP at a single institution was conducted from January 1, 2000 to December 31, 2017, allowing for at least a 6-y follow-up. Eligibility included patients less than 18 y undergoing index ARP. Age, weight, comorbidities, and ARM use were collected. Operative information included procedure type and hospital course. Postoperative information included complications, reoperation, postoperative symptoms, and postoperative ARMs. <em>t</em>-Tests compared continuous outcomes, while chi-square test compared frequency of categorical outcomes.</div></div><div><h3>Results</h3><div>In total, 305 patients were included with a mean (standard deviation) age of 7.2 (6.5) y. In total, 54.7% of patients were male; 70.7% were White, 23% Hispanic, and 5.7% Black. The procedure was laparoscopic for 99.3% and open for 0.7% (<em>n</em> = 2). The most common preoperative symptoms were regurgitation (53.4%) and retrosternal pain (9.2%). Postoperatively, regurgitation remained the most common at 30.8% (<em>n</em> = 94). The most common comorbidities were neurodevelopmental delay (42%, <em>n</em> = 128) and asthma (35.7%, <em>n</em> = 109). 11.8% (<em>n</em> = 33) underwent reoperation. Subsequently, 2.4% (<em>n</em> = 7) of the patients were within 90 d of operation, most commonly for wrap slippage (<em>n</em> = 11) or hiatal hernia (<em>n</em> = 9). AMRs were discontinued in 39.8% (<em>n</em> = 80) of the patients within 30 d and 57.4% (<em>n</em> = 156) at most recent follow-up. It appeared most efficacious for neurodevelopmental delay patients. The mean follow-up was 10 y.</div></div><div><h3>Conclusions</h3><div>More than half of the patients discontinued ARMs following ARP suggesting that surgery remains beneficial in reducing long-term medication use.</div></div>\",\"PeriodicalId\":17030,\"journal\":{\"name\":\"Journal of Surgical Research\",\"volume\":\"311 \",\"pages\":\"Pages 112-117\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022480425002343\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022480425002343","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Long-term Efficacy of Pediatric Anti-reflux Surgery in Reduction of Acid-reducing Medication
Introduction
Revision of anti-reflux procedures (ARPs) has contributed to a shift away from surgical management of pediatric gastroesophageal reflux disease. Long-term proton-pump inhibitor and H2 antagonist use, however, is associated with infection and micronutrient malabsorption. This study investigates long-term ARP efficacy in decreasing acid-reduction medication (ARMs) usage.
Methods
A retrospective cohort study of pediatric patients undergoing ARP at a single institution was conducted from January 1, 2000 to December 31, 2017, allowing for at least a 6-y follow-up. Eligibility included patients less than 18 y undergoing index ARP. Age, weight, comorbidities, and ARM use were collected. Operative information included procedure type and hospital course. Postoperative information included complications, reoperation, postoperative symptoms, and postoperative ARMs. t-Tests compared continuous outcomes, while chi-square test compared frequency of categorical outcomes.
Results
In total, 305 patients were included with a mean (standard deviation) age of 7.2 (6.5) y. In total, 54.7% of patients were male; 70.7% were White, 23% Hispanic, and 5.7% Black. The procedure was laparoscopic for 99.3% and open for 0.7% (n = 2). The most common preoperative symptoms were regurgitation (53.4%) and retrosternal pain (9.2%). Postoperatively, regurgitation remained the most common at 30.8% (n = 94). The most common comorbidities were neurodevelopmental delay (42%, n = 128) and asthma (35.7%, n = 109). 11.8% (n = 33) underwent reoperation. Subsequently, 2.4% (n = 7) of the patients were within 90 d of operation, most commonly for wrap slippage (n = 11) or hiatal hernia (n = 9). AMRs were discontinued in 39.8% (n = 80) of the patients within 30 d and 57.4% (n = 156) at most recent follow-up. It appeared most efficacious for neurodevelopmental delay patients. The mean follow-up was 10 y.
Conclusions
More than half of the patients discontinued ARMs following ARP suggesting that surgery remains beneficial in reducing long-term medication use.
期刊介绍:
The Journal of Surgical Research: Clinical and Laboratory Investigation publishes original articles concerned with clinical and laboratory investigations relevant to surgical practice and teaching. The journal emphasizes reports of clinical investigations or fundamental research bearing directly on surgical management that will be of general interest to a broad range of surgeons and surgical researchers. The articles presented need not have been the products of surgeons or of surgical laboratories.
The Journal of Surgical Research also features review articles and special articles relating to educational, research, or social issues of interest to the academic surgical community.